Covalon Technologies Ltd. (TSXV:COV)
Canada
· Delayed Price · Currency is CAD | Market Cap | 66.08M |
| Revenue (ttm) | 33.84M |
| Net Income (ttm) | 3.70M |
| Shares Out | 27.42M |
| EPS (ttm) | 0.14 |
| PE Ratio | 17.06 |
| Forward PE | 30.13 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,826 |
| Average Volume | 9,266 |
| Open | 2.400 |
| Previous Close | 2.410 |
| Day's Range | 2.380 - 2.450 |
| 52-Week Range | 2.010 - 4.300 |
| Beta | 0.10 |
| RSI | 46.08 |
| Earnings Date | May 28, 2025 |
About Covalon Technologies
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by second... [Read more]
Financial Performance
Financial StatementsNews
Covalon Technologies Ltd. (CVALF) Q2 2025 Earnings Call Transcript
Covalon Technologies GAAP EPS of $0.02, revenue of $7.59M beats by $2.2M
Covalon Reports Fifth Consecutive Quarter of Positive Earnings
Year-To-Date Revenue Grew 21% and Year-To-Date Adjusted EBITDA Increased by 57% MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced med...
Covalon Reports Fifth Consecutive Quarter of Positive Earnings
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 secon...
Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard
Study results have been selected for presentation at two prestigious scientific meetings and are advancing to publication MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) ...
Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that exciting results...
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2025 Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2025 finan...
Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has engaged O...
Covalon Announces Promotion of Kim Crooks to Chief Operating Officer and Appointment to Board of Directors
MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce the promotion of Ms. Kim Crook...
Covalon Announces Promotion of Kim Crooks to Chief Operating Officer and Appointment to Board of Directors
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce the promotion ...
Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be prese...
Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025
MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that they will be presenting at the P...
Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that they will be pre...
Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company is pleased to announce the very positi...
Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders
MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon...
Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the ma...
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 19, 2025
MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders...
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 19, 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting...
Covalon Technologies Ltd. 2025 Q1 - Results - Earnings Call Presentation
Covalon Technologies Ltd. (CVALF) Q1 2025 Earnings Call Transcript
Covalon Technologies GAAP EPS of $0.04, revenue of $8.17B beats by $8.17B
Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 first...
Covalon Technologies Ltd. Named as a TSX Venture Exchange 2025 Top 50 Company
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that it has be...
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2025 Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2025 finan...
Covalon Technologies Releases Statement on United States – Canada Trade Dispute
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today released a statement on the tar...